Now showing items 1-2 of 2

    • Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients. 

      Elashoff, Michael R; Wingrove, James A; Beineke, Philip; Daniels, Susan E; Tingley, Whittemore G; Rosenberg, Steven; Voros, Szilard; ... (16 authors) (BMC Med Genomics, 2011-03-28)
      BACKGROUND: Alterations in gene expression in peripheral blood cells have been shown to be sensitive to the presence and extent of coronary artery disease (CAD). A non-invasive blood test that could reliably assess obstructive ...
    • Downstream coronary effects of drug-eluting stents. 

      Krasuski, Richard A; Cater, George M; Devendra, Ganesh P; Wolski, Kathy; Shishehbor, Mehdi H; Nissen, Steven E; Oberti, Carlos; ... (8 authors) (Am Heart J, 2011-10)
      BACKGROUND: Antiproliferative agents used in drug-eluting stents (DES) attenuate atherosclerosis, yet DES implantation has been linked to endothelial dysfunction. The downstream effects of DES on new lesion formation have ...